SGHT: Strong growth in glaucoma and dry eye platforms, with new products and expanded market access ahead
The business has shifted to a high-growth, dual-platform model with strong momentum in both glaucoma and dry eye interventions. Recent payer wins, product innovation, and operational discipline are driving revenue growth and expanding market access, with new product launches and pipeline developmen…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.